Collegium Pharmaceutical, Inc.COLLNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 310 | 277↓10.7% | 464↑67.6% | 567↑22.2% | 631↑11.4% |
| Gross Profit | 180 | 151↓16.2% | 209↑39.1% | 326↑55.7% | 377↑15.7% |
| Operating Income | 56 | 18↓68.7% | 33↑89.0% | 167↑401.1% | 170↑1.8% |
| Net Income | 27 | 72↑167.3% | -25↓135.0% | 48↑292.6% | 69↑43.7% |
| EBITDA | 118 | 87↓26.7% | 173↑100.2% | 308↑77.9% | 342↑10.8% |
| EPS Diluted | 0.76 | 1.86↑144.7% | -0.74↓139.8% | 1.29↑274.3% | 1.86↑44.2% |